All Type of News
Trius Therapeutics announces positive phase II results on TR-701
Trius Therapeutics, Dong-A Pharmaceutical’s U.S. partner announced on June 10 that it gained the positive results from its Phase 2 clinical trial evaluating the safety and efficacy of oral TR-701, its investigational ...
Ilyang exports ilaprazole to Indonesia
Ilyang Pharm said June 8 it has signed a memorandum of understanding (MOU) to supply an Indonesian company with ilaprazole 10 mg and 20 mg as a finished product, an antiulcer drug, under the trade name of Noltec
D...
Daiichi Sankyo Korea, Daewoong to co-promote hypertensive agent in combination form
Daiichi Sankyo Korea has joined hands with Daewoong Pharm to market Sevicar, a combination of the angiotensin II receptor antagonist olmesartan, and the calcium channel blocker amlodipine) from July 10.
Sevicar is ...
Chong Kun Dang, Boram team up for anti-obesity market
Chong Kun Dang Pharmaceutical Co. has teamed up with Boram Pharm to market Lakshmi (orlistat), a beauty goddess of Indian legend, in the local anti-obesity market.
Industry watchers expect the domestic anti-impoten...
Price of NovoSeven injection angers hemophilia patients
The final health insurance price for NovoSeven (recombinant activated clotting factor VII ~ rFVIIa) injection 240 KIU (4.8 mg) will be finally decided by the Ministry for Health, Welfare and Family Affair committee, s...
Glivec price to be lowered by 14%
The government decided to reduce the insurance price of Glivec, leukemia drug, by 14 percent at the request of patients and civic groups, it was announced on June 8.
Under such decision, the insurance price of Gliv...
Insurance prices of 4,123 medicines to be re-evaluated in 2009
The Ministry of Health, Welfare and Family Affairs announce on June 8 that the price of 4,123 drugs, which were approved before April 31, 1999, will be re-evaluated within this year.
The government is evaluating th...
New flu vaccines to be produced by Green Cross soon
Green Cross Corporation plans to mass-produce new influenza vaccines by cultivating master seeds supplied by the U.S. Centers for Disease Control and Prevention (CDC) and the U.K. National Institute for Biological Sta...
Government to tighten controls on banned chemicals
The government will strengthen controls over manufacture, export and import of chemicals that can be used to make narcotics, in line with a global effort to prevent the flow of such substances, health authorities said...
139 excipients to be under strict regulation
The Korea Food and Drug Administration plans to bring a total of 3,111 medicinal ingredients, including 139 excipients and additives, under probe as part of its efforts to firmly establish a better system to strictly ...
